Viral Strategy Uses Mitochondrial Remodeling to Evade Immune Response and Identify New Drug Opportunities
Scientists at The Wistar Institute have discovered how herpesviruses manipulate mitochondrial structure to evade immune responses, offering new drug development targets to treat virus-related diseases.
Researchers at The Wistar Institute have uncovered a novel mechanism employed by certain viruses to manipulate mitochondrial architecture, effectively silencing the host's immune response and facilitating viral replication. Published in Nature Microbiology, the study reveals how the viral protein vBcl-2, associated with Kaposi's sarcoma-linked herpesvirus (KSHV), exploits a host enzyme, NM23-H2, to induce mitochondrial fragmentation. This structural change prevents the formation of the MAVS signaling platform, a crucial component for antiviral defense mechanisms like Type I interferon production.
Traditionally known for its role in inhibiting cell death, vBcl-2 was found to have a more sophisticated function: remodeling mitochondria during a specific phase of the viral lifecycle. By activating NM23-H2, vBcl-2 promotes mitochondrial fission, disrupting immune signaling and enabling the virus to complete its late-stage assembly and exit the cell.
This process effectively destabilizes the immune response, preventing the activation of key antiviral proteins such as TRIM22 and MxB, which normally trap viral particles and inhibit their release. Furthermore, the team identified a small molecule, VBNI-1, capable of interfering with the vBcl-2 and NM23-H2 interaction. VBNI-1 successfully blocked mitochondrial fission and restored immune signaling pathways in laboratory models without harming uninfected cells, marking it as a promising candidate for targeted antiviral therapy.
The discovery highlights a potential new therapeutic target—the virus-induced mitochondrial remodeling process—and opens avenues for drug development against KSHV and other herpesviruses that may employ similar tactics. This interdisciplinary research underscores the importance of understanding virus-host interactions at the cellular level, paving the way for innovative treatments for virus-associated diseases.
For more details, see the full study here.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Microscopic Pores in Brain Cells Could Unlock Mysteries of Parkinson's Disease
New research uncovers how tiny, dynamic pores formed by toxic proteins in brain cell membranes may be a key factor in Parkinson's disease development, paving the way for early detection and targeted therapies.
Higher Maternal BMI During Early Pregnancy Increases Risk of Childhood Overweight and Obesity
Higher BMI in women during early pregnancy significantly increases the likelihood of their children developing overweight or obesity by age ten. Supporting women before conception is essential to break the cycle of intergenerational obesity.
How Accurate Are Your Medical Records? Uncovering Common Errors and Their Impact
Discover the prevalence of errors in medical records, their potential risks, and strategies to improve accuracy. Learn how healthcare professionals, institutions, and patients can work together to ensure safer, more reliable medical documentation.
Increasing Dizziness Cases in Minnesota Clinics Reflect Growing Awareness and Treatment Options
Minnesota clinics are seeing a rise in patients seeking care for dizziness and balance issues, driven by an aging population and improved treatment options. Advances in diagnosis and therapy are helping patients manage vertigo and prevent falls. Read more about the growing focus on vestibular health in Minnesota.